FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement 
Zelenskiy Awaits U.S. Details as Ukraine Prepares for Possible Peace Talks Next Week 
U.S.–Venezuela Relations Show Signs of Thaw as Top Envoy Visits Caracas 
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 
U.S. and Israeli Military Leaders Hold Pentagon Talks as Tensions With Iran Escalate 
Laura Fernandez Set to Become Costa Rica’s Next President, Promising Sweeping Political Change 
Why Trump’s new pick for Fed chair hit gold and silver markets – for good reasons 
Russian Drone Strike Kills Miners as Ukraine Pushes for Peace Talks Amid Energy Crisis 
Keir Starmer Urges Prince Andrew to Testify in U.S. Epstein Investigation 
Christian Menefee Wins Texas Special Election, Narrowing GOP House Majority 
Trump Orders DHS to Avoid Protests in Democratic Cities Unless Federal Assets Are Threatened 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
U.S. President Donald Trump revealed on Saturday that his administration will deliver an important update on autism this Monday, sparking speculation about new health findings. Speaking at a dinner hosted by the conservative American Cornerstone Institute, Trump described it as “one of the most important things that we will do,” but declined to share details.
The Wall Street Journal recently reported that Health Secretary Robert F. Kennedy Jr. is preparing to announce potential risks tied to Tylenol, a popular pain reliever from Kenvue. According to the report, Kennedy may claim that using Tylenol during pregnancy could be linked to autism, a position that contradicts existing medical guidelines which deem the drug safe.
Autism diagnoses in the United States have climbed dramatically in recent decades, fueling ongoing debate. Data from the Centers for Disease Control and Prevention (CDC) shows that autism prevalence among 8-year-olds reached 1 in 36 in 2020 (2.77%), compared with 2.27% in 2018 and just 0.66% in 2000. Kennedy has repeatedly stated that America is facing an “autism epidemic” driven by environmental toxins, though most scientists argue the condition likely stems from a mix of genetics and environmental factors.
In addition to the autism update, Trump teased another policy rollout. He announced that Mehmet Oz, head of the Centers for Medicare and Medicaid Services, will unveil a “most favored nation” drug pricing model. This initiative aims to lower U.S. prescription drug costs by matching the lowest prices paid by other Organisation for Economic Co-operation and Development (OECD) countries. Trump emphasized that tariffs could be used against nations resisting fair pricing, calling Dr. Oz “a smart, tough guy” who could drive the plan forward.
